-
Study aim
-
Determining the Effects of Curcumin (Oral) on Perineal Pain Intensity and Episiotomy Wound Healing Rate in Postpartum Women
-
Design
-
Participants (n=59, accounting for a 10% attrition rate, thus n=66 initially) will be randomly allocated, for example, based on odd and even numbers, into two groups (30 participants each): the intervention group (curcumin consumers) and the control group (non-curcumin consumers). The study will be conducted in selected educational hospitals in Isfahan province.
-
Settings and conduct
-
Pre-Intervention: Record baseline data (age, height, weight, medical history, delivery status).
Baseline Assessment: Measure pain (VAS) and wound status (REEDA) 4 hours post-episiotomy, before intervention.
Follow-up: Assess pain (VAS) and wound status (REEDA) on postpartum days 7 and 10 by a trained researcher.
Standardization: Ensure consistent episiotomy type, repair, suture, local anesthetic, and analgesics to minimize confounding variables.
Intervention Group: Curcumin supplement until postpartum day 10.
Control Group: No curcumin.
Location: Educational hospitals in Isfahan province.
-
Participants/Inclusion and exclusion criteria
-
Gestational age between 37 to 42 full weeks, no sensitivity to turmeric, presence of a single live fetus, normal body mass index, mediolateral episiotomy, women must be breastfeeding and willing to continue breastfeeding, no consumption of specific analgesics, no use of specific medications and no history of chronic systemic diseases.
-
Intervention groups
-
Intervention Group: Received curcumin supplementation until day 10 postpartum.
Control Group: No curcumin consumption
-
Main outcome variables
-
Perineal pain severity, Episiotomy wound healing rate